Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
921 to 940 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| R01GM065307 | Structure, Function and Inhibition of [4Fe-4S] Proteins | 1 | 2017 |
| R01GM113052 | Stress regulated mitochondrial dynamics | 1 | 2017 |
| R01HD076450 | The role of REST in the pathogenesis of uterine fibroids | 1 | 2017 |
| R01HG008688 | Base-resolution sequencing of m6A in RNA | 1 | 2017 |
| R01HL086582 | Reversing the effects of donor aging on adult stem cell potential | 1 | 2017 |
| R01HL088498 | Canonical Wnt Signaling in Pathogenesis and Rescue of ARVC | 1 | 2017 |
| R01HL095077 | Mycardial Repair Using Human iPSC Derived Cardiac Muscle Patch | 1 | 2017 |
| R01HL117163 | Beta-adrenergic signaling: double edged sword of myocardial repair | 1 | 2017 |
| R01HL119824 | Hyaluronan enhanced polymeric heart valve prosthesis | 1 | 2017 |
| R01HL119967 | Endocardial Pathways Regulated by Tbx20 | 1 | 2017 |
| R01HL122525 | Enhanced Myocardial Repair with CardioClusters and CardioChimeras | 1 | 2017 |
| R21AA024210 | Effect of alcohol on biogenesis and function of amniotic exosomal exRNA | 1 | 2017 |
| R21CA192072 | Defining the Germline Genomic Landscape of a Novel GIST Multi-tumor Syndrome | 1 | 2017 |
| R21CA209045 | Systemic delivery of miR-29 for basal-like breast cancer treatment | 1 | 2017 |
| R24OD018259 | Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy | 1 | 2017 |
| R24OD018555 | Development of Aquatic Model Resources for Therapeutic Screens | 1 | 2017 |
| R37HL091102 | Stem Cell Signaling in the Pathologically Challenged Myocardium | 1 | 2017 |
| S10OD021502 | A NanoLC-Orbitrap Tribrid Instrument for Comprehensive Proteomics Analyses | 1 | 2017 |
| S10OD021743 | High Throughput Sequencing System for KUMC Genomics Core | 1 | 2017 |
| S10OD023680 | High-Performance Computer Cluster for Biomedical Research | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=47